Chief Executive Officer · Pediatrix Medical Group, Inc. (MD)

Mark Ordan

A named executive officer of Pediatrix Medical in every fiscal year CompBrief holds from FY2020 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$14,140,217

Salary $970,014Stock awards $8,456,024Bonus $2,000,000

FY2020: $6,438,682

1st of 5 named executive officers at Pediatrix Medical by FY2025 total.

5 named officers on file for Pediatrix Medical, FY2025

Mark Ordan’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • MD’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Pediatrix Medical’s whole pay program stands against its peers

  • Pediatrix Medical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 27, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Mark Ordan’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Ordan compensation by year

Pediatrix Medical Summary Compensation Table · all 2 fiscal years held
In US dollars, as Pediatrix Medical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2025
Salary$471,014$970,014
Bonus$0$2,000,000
Stock awards$1,999,992$8,456,024
Option awards$3,000,006$0
Non-equity incentive$709,016$2,700,000
Pension and deferred compensation$0$0
All other$258,654$14,179
Total$6,438,682$14,140,217

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Pediatrix Medical Group, Inc. DEF 14A filed March 27, 2026, accession 0001193125-26-127299, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Pediatrix Medical Group, Inc. filed document, accession 0001193125-26-127299. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2026.

$6.4M
$14.1M
FY20
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU640,000$13,689,600—
RSU194,347$4,157,082—
PSU64,783$1,385,708—

Per the Outstanding Equity Awards at Fiscal Year-End table in Pediatrix Medical Group, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

4 Form 4 lines since the FY2025 proxy (filed March 27, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-02Disposition to the issuer—97,174$0.00313,710
2026-06-02Grant or award—97,174$0.00410,884
2026-06-01Tax withholding—19,119$21.54410,884
2026-06-01Grant or award—127,198$0.00430,003

The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Pediatrix Medical’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Mark Ordan · this pageChief Executive Officer$14,140,217
Don NeebExecutive Vice President, Chief Investment & Strategy Officer$5,317,268
Mary Ann MooreExecutive Vice President, General Counsel, Chief Administrative Officer and Secretary$3,031,152
James SwiftFormer Chief Executive Officer$2,775,881
Kasandra RossiExecutive Vice President, Chief Financial Officer and Treasurer$1,860,037

Board service

Pediatrix Medical board · FY2023–FY2025
Director compensation in US dollars, as Pediatrix Medical reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$34,134$0——$34,134
FY2024$980,000$150,001——$1,130,001
FY2023$425,000$129,454——$554,454

Each year as the company reported it in Pediatrix Medical's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Pediatrix Medical pays directors a $95,000 cash retainer and $165,000 in RSUs. As stated in Pediatrix Medical's FY2025 proxy.

The full Pediatrix Medical compensation record

free company brief

This page is one person within Pediatrix Medical's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Pediatrix Medical proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Pediatrix Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Ordan's compensation dossier · One-time report. No refunds.